Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care.

Alessandro BosiYunwen XuAlessandro GaspariniBjörn WettermarkPeter BaranyRino BelloccoLesley A InkerAlex R ChangMara Ann McAdams-DeMarcoMorgan E GramsJung-Im ShinJuan Jesús Carrero

Published in: Clinical kidney journal (2021)

One in five patients with CKD received nephrotoxic medications in two distinct health systems. Strategies to increase physician's awareness of patients' CKD and knowledge of drug nephrotoxicity may reduce prescribing nephrotoxic medications and prevent iatrogenic kidney injury.

Keyphrases

chronic kidney disease
end stage renal disease
healthcare
primary care
peritoneal dialysis
ejection fraction
emergency department
palliative care
clinical practice
drug induced
adverse drug
patient reported outcomes
chronic pain
pain management
electronic health record